![]() ![]() ![]() ![]() Identify the long-term root causes affecting the availability of long-term finance for growing innovative firms, including any barriers that investors may face in providing long-term finance The terms of reference set out that the review would:Ĭonsider the availability of long-term finance for growing innovative firms looking to scale up The review, which was led by HM Treasury, identified barriers to access to long-term finance for growing firms. The Patient Capital Review was announced by the Prime Minister in November 2016. HM Treasury published a consultation seeking views on how to increase the supply of capital to growing innovative firms. ![]()
0 Comments
Leave a Reply. |